If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.02 (0.74%)
Bid:
2.60
Ask:
2.82
Spread: 0.22 (8.462%)
Market Cap: £4.74m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Partnership with Plessey Semiconductors

4 Jan 2019 07:00

RNS Number : 1741M
Nanoco Group PLC
04 January 2019
 

04 January 2019

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

Nanoco and Plessey partner to shrink full-colour microLED pixels by 87% using quantum dots

Process enables production of smaller, higher-resolution and more energy efficient microLED displays 

MANCHESTER, UK & CONCORD, Mass. USA, January 3, 2019: Plessey Semiconductors and Nanoco Technologies today announced a partnership to shrink the pixel size of monolithic microLED displays using Nanoco's cadmium free quantum dot (CFQD® quantum dots) semiconductor nanoparticle technology. Using its existing monolithic process, Plessey will integrate the Nanoco CFQD® quantum dots into selected regions of blue LED wafers to add red and green light. This shrinks the smallest practical pixel size from today's 30µm to just 4µm, a reduction of 87%. The process will enable the production of smaller, higher-resolution, microLED displays in applications such as AR/VR devices, watches, and mobile devices, while enhancing both colour rendition and energy efficiency.

For pixels of 30µm or greater, colour conversion is currently performed by adding phosphors to the blue die. However, since the smallest phosphor particle is around 30µm, the efficiency of colour conversion deteriorates as the pixel size shrinks. Nanoco's CFQD® quantum dot technology overcomes this limitation while facilitating efficient, compact device packaging.

"Quantum dots offer the best solution for today's emerging display requirements. The nano-sized emitters with narrow band emission make them a suitable solution for Plessey's microLED display roadmap, which will see pixels being driven down to 4µm in size by 2019," said Mike Lee, President of Corporate and Business Development at Plessey.

Dr. Brian Gally, Nanoco's Head of Product commented: "We are thrilled to be working in close collaboration with Plessey, who lead the global field in the development and production of microLED arrays. The combination of Plessey's blue microLEDs with Nanoco's red and green cadmium free quantum dots gives display customers the performance they require to rapidly commercialise products."

Compared with all other display technologies, microLEDs are brighter, smaller, lighter, more energy-efficient and have a longer operating life. Where they replace OLEDs, for example in AR/VR goggles or head-up displays, Plessey microLEDs offer ten times the resolution, 100 times the contrast ratio, and up to 1,000 times the luminance. They do so at half the power consumption, doubling battery life in portable devices. They also feature perfect blacks, realistic colour, and immunity to burn-in or decay over time.

 

Plessey was recently named as a 'CES 2019 Innovation Awards Honoree.' The company will be showcasing its microLED technology at the event in the Las Vegas Convention Center, South Hall 1, stand 22048.

 

Visitors can schedule a demo or meeting at CES, held in Las Vegas between the 8th and 11th of January, email marketing@plesseysemi.com

 

About Plessey

Plessey is a UK-based leading developer of advanced optoelectronic technologies. The company provides volume processing of its unique and proprietary GaN-on-silicon platform for a wide range of optoelectronic devices and systems.

With headquarters located in Plymouth, England, Plessey operates leading-edge 150mm and 200mm wafer processing facilities to undertake design, test and assembly of products, and a comprehensive suite of photonic characterization and applications laboratories.

Plessey is an award-winning provider of innovative illuminators for display engines (DMD and LCOS) and full-field emissive microLED displays that combine very high-density RGB pixel arrays with high-performance CMOS backplanes to produce very high-brightness, low-power and high-frame-rate image sources for head-mounted displays (HMDs), and augmented reality (AR) and virtual reality (VR) systems.

For further information and datasheets, please visit www.plesseysemiconductors.com oremail sales@plesseysemi.com. You can also follow Plessey on TwitterFacebook and LinkedIn.

 

About Nanoco Group plc

Nanoco harnesses the power of advanced nano-materials by producing innovative quantum dots to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's CFQD® quantum dots are free of cadmium and can be tuned to absorb and emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of commercial applications including displays, lighting, sensors and biological imaging.

Nanoco has licensed its technology to The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan for use in display applications.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated by its innovation engine.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. To learn more, visit: www.nanocogroup.com.

 

Contact for editorial information

Nayl D'Souza, Account Director, Publitek

Tel: +44 (0)20 3813 6423

Email: nayl.dsouza@publitek.com 

 

Contact for Nanoco company information

Colleen Irish

Tel: +1 617-842-1511

Email: cirish@tieronepr.com 

 

Contact for Plessey company information

Sam Langridge, Marketing Manager

Email: sam.langridge@plesseysemi.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAVXLFBKFFFBBD
Date   Source Headline
1st Jul 202610:24 amRNSPDMR Shareholding and Deferred Bonus Options
26th Jun 20267:00 amRNSCommencement of Shareholder Consultation
25th Jun 20267:00 amRNSBoard Update
19th Jun 202610:33 amRNSAdjournment of General Meeting
18th Jun 20267:00 amRNSIntention to adjourn General Meeting
9th Jun 20267:00 amRNSGlass Lewis recommendation
5th Jun 202611:55 amRNSTR-1: Notification of major holdings
27th May 20267:00 amRNSIntention to delist from London Stock Exchange
20th Apr 20265:37 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSInterim Results
13th Apr 20267:00 amRNSNotice of Results
26th Mar 20267:00 amRNSShoei Litigation Conclusion
19th Mar 20267:00 amRNSStay of Shoei Litigation
23rd Feb 20267:00 amRNSShoei Litigation Update
26th Jan 20267:00 amRNSConclusion of CDX process & Directorate changes
15th Jan 20261:08 pmRNSReceipt of Litigation Proceeds
13th Jan 20264:50 pmRNSResult of AGM
12th Jan 20267:00 amRNSLitigation update
9th Dec 20257:00 amRNSBlocklisting Six-Monthly Return
8th Dec 202511:16 amRNSNotice of AGM
27th Nov 20257:00 amRNSResponse to non-infringement claim
26th Nov 20257:00 amRNSAnnual Report and Accounts
20th Nov 20257:00 amRNSLitigation outcome – Settlement agreed
18th Nov 20257:07 amRNSPreliminary Results
13th Nov 20257:00 amRNSNotice of Results
4th Nov 20257:06 amRNSExtension of Joint Development Agreement
15th Oct 20257:00 amRNS-RAwarding of Government Grant
30th Sep 20254:30 pmRNSTotal Voting Rights and Share Capital
8th Sep 20257:00 amRNSIssue of Equity and Director/PDMR Shareholdings
19th Aug 20257:00 amRNSFull Year Trading Update & Director Retirement
9th Jun 20257:00 amRNSBLOCKLISTING SIX-MONTHLY RETURN
28th Apr 202510:48 amRNSJoint Development Agreement
25th Apr 20257:00 amRNSPatent infringement lawsuit against LG
17th Apr 20253:54 pmRNSHigh Court Confirmation of Capital Reduction
15th Apr 20257:00 amRNSInterim Results & Investor Presentation
13th Mar 20257:00 amRNSNotice of Results
21st Jan 20252:20 pmRNSAnnual General Meeting – Voting Results
18th Dec 20248:26 amRNSDirector/PDMR Shareholding
13th Dec 20241:23 pmRNSResult of General Meeting
9th Dec 20247:00 amRNSBlock Listing Six Monthly Return
6th Dec 20246:30 pmRNSNotice of AGM
29th Nov 20247:00 amRNSGlass Lewis and ISS recommendations
28th Nov 20243:23 pmRNSDirector/PDMR Shareholding
28th Nov 20241:25 pmRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNS2024 Annual Report
20th Nov 20247:00 amRNSPreliminary Results
15th Nov 202411:00 amRNSPosting of Circular and Notice of General Meeting
30th Oct 20247:01 amRNSCompletion of Buyback Programme
30th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.